SG3 Ventures is an early stage life science venture capital firm. The firm's primary focus in on therapeutics and digital health. SG3 invests in the greater Philadelphia Region (Princeton to the north, Baltimore to the south and Pittsburgh to the west). It prefers to make initial investments at the formation or seed stage with a focus on providing financing through mature rounds of investment. The firm is based in Philadelphia, Pennsylvania and was founded in 2015.